Orion (ORNBV FH) Q1 2026 (EUR): Sales 417.7mln (exp. 426.1mln); FY Sales Outlook 1.95-2.1bln (exp. 2.07bln)

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

New York Mayor Mamdani reportedly to consider delaying pension fund payments, NYT reports

[MARKET ANALYSIS] European bourses mostly lower; Nestle +7% post-earnings

Orion (ORNBV FH) Q1 2026 (EUR): Sales 417.7mln (exp. 426.1mln); FY Sales Outlook 1.95-2.1bln (exp. 2.07bln)

US to speed up payments for new medical devices, FT reports

[MARKET ANALYSIS] USD and NOK outperform, GBP shrugs off political instability as PMIs firm, NZD underperforms

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

Context

Orion's Q1 2026 sales missed expectations by a notable margin, which could raise concerns over the company's growth trajectory. The fiscal year sales outlook also falls short of consensus, suggesting potential headwinds in achieving revenue targets. This could lead to a reevaluation of the stock by investors, focusing on how these results impact the market's perception of Orion's performance and competitiveness.

Related headlines

The feed had this first.

Use the Platform